# Multifaceted roles of CARM1 beyond histone arginine methylation

## TL;DR

The paper explores the diverse roles of CARM1 beyond its traditional function in histone modification, highlighting its impact on cellular processes and potential as a therapeutic target.

## Contribution

The paper emphasizes CARM1's noncatalytic scaffolding functions and proposes novel therapeutic strategies targeting the entire protein.

## Key findings

- CARM1 regulates transcription, RNA processing, metabolism, and organelle dynamics through nonhistone protein substrates.
- CARM1 functions as a scaffold in signaling events independent of its enzymatic activity.
- Proteolysis-targeting chimeras are being explored to degrade CARM1 and inhibit both its catalytic and scaffolding roles.

## Abstract

Coactivator-associated arginine methyltransferase 1 (CARM1), first identified in 1999, has been studied primarily for its nuclear role in epigenetic regulation through histone methylation. Subsequent research has expanded the substrate repertoire to include nonhistone proteins, thus uncovering broader functions in maintaining cellular homeostasis by regulating transcription, RNA processing, metabolism and organelle dynamics. More recently, CARM1 was shown to exert scaffolding functions independent of its catalytic activity, thereby orchestrating key signaling events involved in transcriptional activation, replication stress response and cell cycle control. These findings highlight the multifaceted roles of CARM1 in nuclear and cytoplasmic compartments. Despite substantial progress in the development of selective small-molecule inhibitors, their inability to target noncatalytic functions has limited their therapeutic potential. Consequently, novel strategies, such as proteolysis-targeting chimeras, are being explored to degrade the entire CARM1 protein, thereby abolishing its enzymatic and scaffolding functions. Here this review outlines the evolving functional landscape of CARM1, from its roles as a transcriptional coactivator to a multifunctional regulator of cellular homeostasis, with an emphasis on its enzyme-independent functions, thereby providing novel insights for next-generation therapeutic strategies.

Arginine methylation is a key process in cells, affecting many functions such as gene expression and DNA repair. This study focuses on CARM1, an enzyme involved in this process. Researchers explored the roles of CARM1 beyond its known nuclear functions. They used various experiments, including studies on mice, to understand how CARM1 works in different parts of the cell. CARM1 was initially known for modifying histones to regulate genes. However, it also affects other proteins outside the nucleus, influencing processes such as metabolism and cell structure. The study found that CARM1 can act without its enzyme activity, serving as a scaffold to support other cellular functions. The research highlights the potential of CARM1 as a target for treating diseases such as cancer. By developing inhibitors and new technologies such as proteolysis-targeting chimeras, scientists aim to block both its enzymatic and nonenzymatic roles.

This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.